FortiCore TLIF combines the benefits of PEEK and titanium creating the most scientifically advanced interbody fusion devices. FortiCore interbody fusion devices are comprised of a PEEK center with a deeply porous titanium scaffold. PEEK Optima® by Invibio is also injection molded into the scaffold for exceptional integration. This unique combination of technologies is designed to increase positive outcomes in spinal fusion procedures with the imaging capabilities preferred by surgeons.
Benefits:
- Three-dimensional scaffold which assists in securing the implant
- Designed and manufactured for strong attachment of titanium to PEEK
- Modulus and imaging properties of a PEEK core
- Nanovis uses PEEK-Optima® by InVibio
- Spine surgeon-designed, modern shape for ease of use
- Surgeon-designed instruments for ease of use
- Variety of sizes and lordosis available
About TLIF
A transforaminal lumbar interbody fusion (TLIF) is performed to remove a portion of a disc that is the source of back or leg pain. Bone graft is used to fuse the spinal vertebrae after the disc is removed. TLIF provides fusion of the front and back of the lumbar spine. The front portion of the spine, called the anterior column, is stabilized by the interbody spacer and bone graft. The back portion, or posterior column, is locked in place with pedicle screws, rods and additional bone graft, alongside the backs of the vertebra.
About Nanovis
Nanovis’ mission is to develop science-enhanced, life-improving technologies. The Company’s patented and proprietary regenerative technology 
platforms provide differentiated surface advantages enabling the potential for existing medical devices to achieve new outcomes. Focused on aggressive, sustainable growth across multiple markets, Nanovis is commercializing science-driven platforms: the deeply porous scaffold currently available with the FortiCore line of interbody fusion devices; an advanced nano-surface technology in development; and a surface technology with anti-colonization and anti-microbial capabilities in pre-clinical studies.http://www.nanovisinc.com